Estrogen receptor alpha: Molecular mechanisms and emerging insights

Journal of Cellular Biochemistry

Volumn 114, Issue 10, 2013, Pages 2203-2208

  Candelaria, Nicholes R ^a   Liu, Ka ^a   Lin, Chin Yo ^a  

^a University of Houston   (United States)

Author keywords

COREGULATORS; ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR

Indexed keywords

CAVEOLIN 1; CELL NUCLEUS RECEPTOR; CYCLIC AMP; CYCLOHEXIMIDE; DNA; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GROWTH FACTOR RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HISTONE METHYLTRANSFERASE; LIGAND; PROTEASOME; PROTEASOME INHIBITOR; REGULATOR PROTEIN; RNA POLYMERASE II; SPACER DNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; BINDING SITE; BREAST CANCER; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CHROMOSOME; DNA BINDING; ENDOCRINE DISEASE; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN THERAPY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HORMONE RESPONSE; HUMAN; HUMAN GENOME; IMMUNOPRECIPITATION; LIGAND BINDING; MAMMARY GLAND; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM;

EID: 84882445612     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24584     Document Type: Article

References (68)

1. Anbalagan M, Huderson B, Murphy L, Rowan BG,. 2012. Post-translational modifications of nuclear receptors and human disease. Nucl Recept Signal 10: e001.
2. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE,. 2007. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201-209.
3. Augello MA, Hickey TE, Knudsen KE,. 2011. FOX A1: Master of steroid receptor function in cancer. EMBO J 30: 3885-3894.
4. Burns KA, Korach KS,. 2012. Estrogen receptors and human disease: An update. Arch Toxicol 86: 1491-1504.
5. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M,. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33-43.
6. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M,. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297.
7. Chadwick CC, Chippari S, Matelan E, Borges-Marcucci L, Eckert AM, Keith JC, Jr., Albert LM, Leathurby Y, Harris HA, Bhat RA, Ashwell M, Trybulski E, Winneker RC, Adelman SJ, Steffan RJ, Harnish DC,. 2005. Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity. Proc Natl Acad Sci USA 102: 2543-2548.
8. Conneely OM, Sullivan WP, Toft DO, Birnbaumer M, Cook RG, Maxwell BL, Zarucki-Schulz T, Greene GL, Schrader WT, O'Malley BW,. 1986. Molecular cloning of the chicken progesterone receptor. Science 233: 767-770.
9. Duan R, Porter W, Safe S,. 1998. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation. Endocrinology 139: 1981-1990.
10. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M,. 2007. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res 67: 6477-6483.
11. Emerson BM,. 2002. Specificity of gene regulation. Cell 109: 267-270.
12. Finlin BS, Gau CL, Murphy GA, Shao H, Kimel T, Seitz RS, Chiu YF, Botstein D, Brown PO, Der CJ, Tamanoi F, Andres DA, Perou CM,. 2001. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem 276: 42259-42267.
13. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS,. 2003. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562-4574.
14. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, Velkov S, Ho A, Mei PH, Chew EG, Huang PY, Welboren WJ, Han Y, Ooi HS, Ariyaratne PN, Vega VB, Luo Y, Tan PY, Choy PY, Wansa KD, Zhao B, Lim KS, Leow SC, Yow JS, Joseph R, Li H, Desai KV, Thomsen JS, Lee YK, Karuturi RK, Herve T, Bourque G, Stunnenberg HG, Ruan X, Cacheux-Rataboul V, Sung WK, Liu ET, Wei CL, Cheung E, Ruan Y,. 2009. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 462: 58-64.
15. Gee JM, Eloranta JJ, Ibbitt JC, Robertson JF, Ellis IO, Williams T, Nicholson RI, Hurst HC,. 2009. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival. J Pathol 217: 32-41.
16. Gorski J, Toft D, Shyamala G, Smith D, Notides A,. 1968. Hormone receptors: Studies on the interaction of estrogen with the uterus. Recent Prog Horm Res 24: 45-80.
17. Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, Scrace G, Waterfield M, Chambon P,. 1986. Cloning of the human oestrogen receptor cDNA. J Steroid Biochem 24: 77-83.
18. Gronemeyer H, Gustafsson JA, Laudet V,. 2004. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3: 950-964.
19. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC,. 2002. Production and actions of estrogens. N Engl J Med 346: 340-352.
20. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS,. 2001. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61: 5979-5984.
21. Hah N, Danko CG, Core L, Waterfall JJ, Siepel A, Lis JT, Kraus WL,. 2011. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 145: 622-634.
22. Hall JM, McDonnell DP,. 2005. Coregulators in nuclear estrogen receptor action: From concept to therapeutic targeting. Mol Interv 5: 343-357.
23. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM,. 1985. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 635-641.
24. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS,. 2011. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43: 27-33.
25. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, Hayashi S,. 2002. Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29: 175-192.
26. Ito Y,. 2004. Oncogenic potential of the RUNX gene family: 'Overview'. Oncogene 23: 4198-4208.
27. Janes KA,. 2011. RUNX1 and its understudied role in breast cancer. Cell Cycle 10: 3461-3465.
28. Jeltsch JM, Krozowski Z, Quirin-Stricker C, Gronemeyer H, Simpson RJ, Garnier JM, Krust A, Jacob F, Chambon P,. 1986. Cloning of the chicken progesterone receptor. Proc Natl Acad Sci USA 83: 5424-5428.
29. Jensen EV, Jacobson HI,. 1960. Fate of steroid estrogens in target tissues. In:, Pincus G, Vollmer EP, editors. Biological activities of steroids in relation to cancer. New York: Academic Press. pp 161-174.
30. Jensen EV, Suzuki T, Kawashima T, Stumpf WE, Jungblut PW, DeSombre ER,. 1968. A two-step mechanism for the interaction of estradiol with rat uterus. Proc Natl Acad Sci USA 59: 632-638.
31. Jensen EV, Mohla S, Gorell TA, De Sombre ER,. 1974. The role of estrophilin in estrogen action. Vitam Horm 32: 89-127.
32. Klinge CM,. 2001. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29: 2905-2919.
33. Kong SL, Li G, Loh SL, Sung WK, Liu ET,. 2011. Cellular reprogramming by the conjoint action of ERalpha, FOXA1, and GATA3 to a ligand-inducible growth state. Mol Syst Biol 7: 526.
34. Krum SA, Miranda-Carboni GA, Lupien M, Eeckhoute J, Carroll JS, Brown M,. 2008. Unique ERalpha cistromes control cell type-specific gene regulation. Mol Endocrinol 22: 2393-2406.
35. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA,. 1996. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930.
36. Kumar V, Green S, Staub A, Chambon P,. 1986. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 5: 2231-2236.
37. Langer G, Bader B, Meoli L, Isensee J, Delbeck M, Noppinger PR, Otto C,. 2010. A critical review of fundamental controversies in the field of GPR30 research. Steroids 75: 603-610.
38. Levin ER,. 2005. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19: 1951-1959.
39. Levin ER, Pietras RJ,. 2008. Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Res Treat 108: 351-361.
40. Lin CY, Strom A, Vega VB, Kong SL, Yeo AL, Thomsen JS, Chan WC, Doray B, Bangarusamy DK, Ramasamy A, Vergara LA, Tang S, Chong A, Bajic VB, Miller LD, Gustafsson JA, Liu ET,. 2004. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol 5: R66.
41. Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M, Chiu KP, Lipovich L, Barnett DH, Stossi F, Yeo A, George J, Kuznetsov VA, Lee YK, Charn TH, Palanisamy N, Miller LD, Cheung E, Katzenellenbogen BS, Ruan Y, Bourque G, Wei CL, Liu ET,. 2007. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 3: e87.
42. Lonard DM, O'Malley BW,. 2005. Expanding functional diversity of the coactivators. Trends Biochem Sci 30: 126-132.
43. Lonard DM, O'Malley BW,. 2009. Emerging roles of the ubiquitin proteasome system in nuclear hormone receptor signaling. Prog Mol Biol Transl Sci 87: 117-135.
44. Marino M, Ascenzi P, Acconcia F,. 2006. S-palmitoylation modulates estrogen receptor alpha localization and functions. Steroids 71: 298-303.
45. Merrell KW, Crofts JD, Smith RL, Sin JH, Kmetzsch KE, Merrell A, Miguel RO, Candelaria NR, Lin CY,. 2011. Differential recruitment of nuclear receptor coregulators in ligand-dependent transcriptional repression by estrogen receptor-alpha. Oncogene 30: 1608-1614.
46. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F,. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763.
47. Mohammed H, D'Santos C, Serandour AA, Ali HR, Brown GD, Atkins A, Rueda OM, Holmes KA, Theodorou V, Robinson JL, Zwart W, Saadi A, Ross-Innes CS, Chin SF, Menon S, Stingl J, Palmieri C, Caldas C, Carroll JS,. 2013. Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep 3: 342-349.
48. Nilsson S, Gustafsson JA,. 2002. Estrogen receptor action. Crit Rev Eukaryot Gene Expr 12: 237-257.
49. O'Malley BW, Means AR,. 1974. Female steroid hormones and target cell nuclei. Science 183: 610-620.
50. Otto C, Fuchs I, Kauselmann G, Kern H, Zevnik B, Andreasen P, Schwarz G, Altmann H, Klewer M, Schoor M, Vonk R, Fritzemeier KH,. 2009. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod 80: 34-41.
51. Petz LN, Ziegler YS, Loven MA, Nardulli AM,. 2002. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells. Endocrinology 143: 4583-4591.
52. Pietras RJ, Szego CM,. 1975. Endometrial cell calcium and oestrogen action. Nature 253: 357-359.
53. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER,. 2002. ERs associate with and regulate the production of caveolin: Implications for signaling and cellular actions. Mol Endocrinol 16: 100-115.
54. Soulez M, Parker MG,. 2001. Identification of novel oestrogen receptor target genes in human ZR 75-71 breast cancer cells by expression profiling. J Mol Endocrinol 27: 259-274.
55. Stender JD, Kim K, Charn TH, Komm B, Chang KC, Kraus WL, Benner C, Glass CK, Katzenellenbogen BS,. 2010. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Mol Cell Biol 30: 3943-3955.
56. Stossi F, Likhite VS, Katzenellenbogen JA, Katzenellenbogen BS,. 2006. Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J Biol Chem 281: 16272-16278.
57. Szego CM,. 1957. Primary mechanism of hormonal action on target cells. In:, Bullock TH, editor. Physiological triggers. Washington, DC: American Physiological Society. p 152.
58. Talalay P, Williams-Ashman HG,. 1958. Activation of hydrogen transfer between pyridine nucleotides by steroid hormones. Proc Natl Acad Sci USA 44: 15-26.
59. Tan SK, Lin ZH, Chang CW, Varang V, Chng KR, Pan YF, Yong EL, Sung WK, Cheung E,. 2011. AP-2gamma regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J 30: 2569-2581.
60. Tian J, Berton TR, Shirley SH, Lambertz I, Gimenez-Conti IB, DiGiovanni J, Korach KS, Conti CJ, Fuchs-Young R,. 2012. Developmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice. J Clin Invest 122: 192-204.
61. Toft D, Gorski J,. 1966. A receptor molecule for estrogens: Isolation from the rat uterus and preliminary characterization. Proc Natl Acad Sci USA 55: 1574-1581.
62. Toft D, Shyamala G, Gorski J,. 1967. A receptor molecule for estrogens: Studies using a cell-free system. Proc Natl Acad Sci USA 57: 1740-1743.
63. Wall EH, Hewitt SC, Liu L, Del Rio R, Case LK, Lin CY, Korach KS, Teuscher C,. 2013. Genetic control of estrogen-regulated transcriptional and cellular responses in mouse uterus. FASEB J 27 (5): 1874-1886.
64. Watson PJ, Fairall L, Schwabe JW,. 2012. Nuclear hormone receptor co-repressors: Structure and function. Mol Cell Endocrinol 348: 440-449.
65. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM,. 1986. The c-erb-A gene encodes a thyroid hormone receptor. Nature 324: 641-646.
66. Welboren WJ, van Driel MA, Janssen-Megens EM, van Heeringen SJ, Sweep FC, Span PN, Stunnenberg HG,. 2009. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J 28: 1418-1428.
67. Wilson BJ, Giguere V,. 2008. Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway. Mol Cancer 7: 49.
68. Woodfield GW, Horan AD, Chen Y, Weigel RJ,. 2007. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. Cancer Res 67: 8439-8443.